The Effects of Gynecologic Cancer on Lower Urinary Tract Function





The association between lower urinary tract dysfunction and gynecologic malignancy is linked by the close proximity of the bladder, urethra, and distal ureters to the female genital tract. A testimony to this association by proximity is the higher staging (and worse prognosis) of gynecologic cancers that spread to involve the lower urinary tract. To consider the effects of gynecologic malignancy on lower urinary tract function is actually to consider a number of related questions that must include not only tumor biology (e.g., tumor invasion or compression of urinary structures) but also the standard cancer therapies, including surgery, radiation, and chemotherapy. The answers to these questions are variably supported in the literature and are poorly, if at all, understood. Although urinary tract dysfunction can be the presenting sign of gynecologic malignancy, today more often the treatments of gynecologic cancers are the cause of lower urinary tract problems. Since these treatments frequently include pelvic surgery and often hysterectomy (intrafascial, vaginal, and radical), the question of how hysterectomy affects lower urinary tract function is relevant. Both chemotherapy and radiotherapy are used in the treatment of gynecologic malignancies and can also affect lower urinary tract function; how these treatments affect the lower urinary tract therefore are also relevant. Finally, how the specific gynecologic cancers themselves affect lower urinary tract function should be considered.


The dominant lower urinary tract dysfunction affecting women following treatment of gynecologic malignancy is urinary incontinence. Genitourinary fistulas, a potential cause of urinary incontinence, are an important morbidity associated with gynecologic surgery and historically are linked with gynecologic cancer. The incidence and causes of genitourinary fistula have changed in modern times, and discussion of this topic is found in detail elsewhere in the book. Nonetheless, it is worth considering the topic in isolation as it relates to gynecologic cancer and its treatment. Other long-term lower urinary tract morbidities of gynecologic cancer treatments include ureteral stenosis and hemorrhagic cystitis. Although it is fitting to consider each of these topics, the emphasis of this chapter will be on urinary incontinence.


Understanding the association between urinary incontinence and gynecologic malignancy is hampered on many levels. Age is an important confounder of this association because age influences the occurrence of both pelvic malignancy and urinary incontinence. At the treatment level, differences in surgical and radiotherapy technique also blur any association. To date, most research on the association of urinary incontinence and gynecologic malignancy has examined the effects of radical hysterectomy and pelvic radiation on bladder function. Few studies have been done on the effects of vulvar cancer and radical vulvectomy on the bladder and urethra. No studies have been done on the lower urinary associations of ovarian cancer reflecting a tumor biology and treatment that largely excludes the bladder. Table 42.1 outlines how each gynecologic cancer is linked with the classifications of urinary incontinence.



Table 42.1

Gynecologic Cancers in Relation to Functional Classification of Urinary Incontinence













Incontinence
No “usual” disease or treatment-associated source of urinary incontinence. Mass effect on the bladder or neurotoxicity from chemotherapy may be a source of urinary frequency or urgency.
Vaginal cancer
Bladder dysfunction
Detrusor overactivity
Involuntary contractions (neurologic injury and/or inflammation) following surgery or radiotherapy
Decreased compliance (neurologic injury and fibrosis)
Radical pelvic surgery
Radiotherapy
Detrusor hypersensitivity (neurologic injury and/or inflammation) following radiotherapy
Vesicovaginal fistula
Urethral dysfunction
Intrinsic sphincter deficiency following radiotherapy
Urethrovaginal fistula
Cervical cancer
Bladder dysfunction
Detrusor overactivity
Involuntary contractions (neurologic injury and/or inflammation)
Radical pelvic surgery
Radiotherapy
Decreased compliance (neurologic injury and fibrosis)
Radical pelvic surgery
Radiotherapy
Detrusor hypersensitivity (neurologic injury and/or inflammation)
Radical pelvic surgery
Radiotherapy
Ureterovaginal fistula
Vesicovaginal fistula
Urethral dysfunction
Defective anatomic support following radical pelvic surgery
Intrinsic sphincter deficiency following radiotherapy and/or radical pelvic surgery
Urethrovaginal fistula
Endometrial cancer
If radical pelvic surgery or radiotherapy is used, treatment-associated sources of urinary incontinence are the same as cervical cancer.
Vulvar cancer
Bladder dysfunction
Detrusor overactivity
Involuntary contractions (neurologic injury and/or inflammation) following radiotherapy
Decreased compliance (neurologic injury and fibrosis) following radiotherapy
Detrusor hypersensitivity (neurologic injury and/or inflammation) following radiotherapy
Vesicovaginal fistula
Urethral dysfunction
Defective anatomic support following radical pelvic surgery
Intrinsic sphincter deficiency
Distal urethral resection
Radiotherapy
Urethrovaginal fistula




The Effects of Intrafascial Hysterectomy on Lower Urinary Tract Function


The effects of any surgery can be divided roughly between intraoperative complications and postoperative sequelae. Since the technique for intrafascial or vaginal hysterectomy for benign conditions is largely identical to those done for malignant conditions, with the exception of lymph node sampling, it is reasonable to use this information. It is recognized that the degree of surgical complexity may be greater for those women undergoing an intrafascial hysterectomy for gynecologic cancer.


Intraoperative Injuries to the Lower Urinary Tract during Hysterectomy


Operative complications of intrafascial hysterectomy have been widely investigated with the question of which surgical approach—abdominal, vaginal, laparoscopic, or robotic—is optimal for management of benign disease. The rate of mortality for a benign hysterectomy is approximately 0.1%. Yet, even at this low rate, given that approximately 600,000 hysterectomies are performed annually in the United States, an estimated 600 women die from hysterectomy-related complications each year. The major morbidities of hysterectomy include, but are not limited to, hemorrhage requiring transfusion, infection, pulmonary embolus, wound dehiscence, injury to bowel, nerves, and the lower urinary tract including the bladder and ureter. The overall complication rate ranges between 6% and 19%. Laparoscopic hysterectomy, despite being associated with shorter hospitalizations and better short-term patient function, has consistently been associated with a higher risk of lower urinary tract injuries. The surgeon’s failure to recognize a lower urinary tract injury can complicate matters further both in the short term (e.g., uremia, ileus) and long term (e.g., kidney failure or vesicovaginal or ureterovaginal fistula).


The bladder is the most commonly injured urinary structure in gynecologic surgery for both benign and malignant disease. Overall, the average incidence of bladder injury from major gynecologic surgery (the majority from hysterectomy) is 0.8%. In a Finnish study by of greater than 10,000 hysterectomies, the rate of bladder injury was 0.2%, 0.5%, and 1.3% for vaginal, abdominal, and laparoscopic hysterectomy, respectively. The ureter is the second most commonly injured organ during major gynecologic surgery with abdominal hysterectomy accounting for 86% of all injuries. The Finnish study, reflecting a trend seen among other studies, found the ureter injury rate for vaginal hysterectomy was 0%; after abdominal and laparoscopic hysterectomy, it was 0.2% and 1.1%, respectively.


reported on lower urinary tract injury in women in the United States from 1979 to 2006 based on the National Hospital Discharge Survey. This large cohort includes data on nearly 50 million gynecologic procedures including 11.7 million abdominal hysterectomies, 4.3 million vaginal hysterectomies, 591,069 laparoscopic-assisted vaginal hysterectomies (LAVH), 327,857 supracervical abdominal hysterectomies, 141,938 radical abdominal hysterectomies, and 38,887 laparoscopic supracervical hysterectomies. This study found the bladder injury rate was highest in LAVH (13.8/1000) and vaginal hysterectomy (13.1/1000). The bladder injury rate was 10.3/1000 for supracervical abdominal hysterectomy. Total abdominal hysterectomy, radical abdominal hysterectomy, and laparoscopic supracervical hysterectomy all had the lowest rates of bladder injury at 6.9/1000, 2.2/1000, 0/1000, respectively. Ureteral injury rates were most common with radical hysterectomy at 7.7/1000. This is not unexpected given the extensive dissection around the ureter that is routinely done at the time of a radical hysterectomy for malignancy. Lower ureteral injury rates were seen for vaginal hysterectomy (0.7/1000), supracervical abdominal hysterectomy (0.6/1000), laparoscopic supracervical hysterectomy (0.6/1000), and laparoscopic-assisted vaginal hysterectomy (0/1000). The authors note that the rate of ureteral injury with LAVH in their study may be underestimated as their dataset used procedure codes and an LAVH with a recognized ureteral/bladder injury is likely to be converted to an open procedure.


also addressed the primary surgical indication for women who sustained nonobstetric bladder injuries ( n = 315,755) and found that 21.8% of the cohort with bladder injuries were undergoing surgery for urinary incontinence as compared to 8.1% with bladder injuries who were undergoing surgery for gynecologic malignancy. When looking at the primary indication for surgery in women who sustained ureteral injuries ( n = 109,589), the majority were undergoing surgery for malignancy at 7.5% with endometriosis being the next most common operative indication in women with ureteral injuries at 4.0%. The question of how hysterectomy precipitates urinary tract injury answered in these studies teaches that overall the rate of injury is low but varies with surgical approach, with that likely reflecting case complexity and surgeon experience.


Applying these lessons to the treatment of gynecologic malignancies is complicated by the added complexity and morbidity of lymph node sampling that may be done along with the “standard” intrafascial hysterectomy. Additionally, patient characteristics such as prior pelvic irradiation as may be the case in hysterectomy for cervical cancer, tumor infiltration and distortion of tissues as in ovarian cancer, or morbid obesity as in endometrial cancer can all lead to the potential for increases in ureteral and bladder injuries. Offsetting any rise in urologic injuries that may occur because of this added complexity is the overall greater surgical experience among gynecologic oncologists. Despite these potential confounders, more data are becoming available for injury rates specific to surgical management of gynecologic malignancy. In the largest Gynecologic Oncology Group study comparing laparoscopy with laparotomy for surgical staging of endometrial cancer, looked at operative complications as a secondary outcome. This multi-institutional study found no difference for intraoperative bladder or ureter complications between the surgical approaches, with each at a rate of 1%. The postoperative complication rate of urinary fistula was also no different between the laparotomy and laparoscopy groups at less than 1% each. In a subsequent study, performed a retrospective, multisite study at high-volume cancer centers comparing minimally invasive surgery versus laparotomy in women with high-grade endometrial cancer finding identical urinary tract injury rates at 1/192 for laparotomy and 1/191 for minimally invasive surgery. These data, taken with the improved quality of life scores seen for women undergoing minimally invasive surgical staging for endometrial cancer, have transformed management of this malignancy to one primarily approached laparoscopically or robotically.


Similar minimally invasive management trends are being seen in cervical cancer staging. reported on 42 cases of Type II and III robotic radical hysterectomies and found a bladder injury rate of 0.02% (1/42) and an identical ureteral injury. In the largest published comparative series on radical hysterectomy for cervical cancer, examined 1894 women undergoing radical hysterectomy by various routes and reported rates of bladder and ureteral injury. This study found no statistically significant difference in bladder injury rate by route of surgery with a 2.2% rate for abdominal radical hysterectomy, 2.8% for laparoscopic radical hysterectomy, and 3.0% for robotic radical hysterectomy. There was also no difference seen in ureteral injury rate among the different approaches, with 1.9% for abdominal radical hysterectomy, 0% for laparoscopic radical hysterectomy, and 3.0% for robotic radical hysterectomy.


Postoperative Effects of Hysterectomy on the Lower Urinary Tract


Of the available studies on the postoperative effects of hysterectomy on the lower urinary tract, only one is randomized and all are limited by small size (between 16 and 72 subjects) and short duration (all but one 6 months or less). The message from these studies is conflicting. A minority of studies documents some bladder dysfunction following hysterectomy, whereas the majority finds either no effect or improvement in bladder function. The minority view holds that, with hysterectomy, there is a disruption of the autonomic and sensory nerves to the bladder—a view more substantiated with radical hysterectomy. Retrospective reviews of incontinent patients have uncovered an association between women symptomatic for some lower urinary tract dysfunction (e.g., incontinence, voiding dysfunction) and hysterectomy. A large population study by investigating this issue queried 7949 American women over the age of 65 and found daily urinary incontinence was more common in women who had had previous hysterectomy than those who had not (adjusted odds ratio 1.4; 95% CI 1.1-1.6). Among these retrospective studies, the variability in definitions of urinary incontinence and the unknown indications for hysterectomy (e.g., pelvic organ prolapse) make interpretation of their results difficult. Furthermore, these studies are hindered by selection and/or recall bias.


, in a prospective study of 43 women before and after hysterectomy, found no change in reported stress or urge incontinence at a mean follow-up of 14.2 months. Yet studies that find either no association or a beneficial effect of hysterectomy on bladder function could suffer from inadequate follow-up times to uncover the issues seen in the long-term population-based studies. Notably, a number of studies have compared urodynamic findings before and after hysterectomy and all have found no significant changes in mean cystometric capacity, occurrence of spontaneous detrusor contractions, postvoid residual volumes, or uroflowmetry values. Taken together, the quality evidence available to date supports the conclusion that intrafascial hysterectomy is unlikely to cause any lower urinary tract dysfunction in the short term and any long-term effects are unclear.




The Effects of Radical Hysterectomy on Lower Urinary Tract Function


The radical hysterectomy introduced by Wertheim in 1912 has proved to be an effective treatment for early stage cervical cancer. Fortunately, many of the early morbidities have been ameliorated. In Wertheim’s original series, 6.8% of patients developed vesicovaginal fistulas, and 6.4% developed ureterovaginal fistulas. Lesser morbidities such as urinary incontinence were not considered. Today, however, with a fistula rate of approximately 1%, urinary incontinence has become the dominant surgery-related morbidity. Rates of lower urinary tract dysfunction following radical hysterectomy range between 20% and 80%. Types of lower urinary tract dysfunction following radical hysterectomy include voiding dysfunction (e.g., abdominal straining, slow flow, urinary retention), storage dysfunction (e.g., decreased capacity or sensation, elevated postvoid residual volumes), recurrent urinary tract infections, and urinary incontinence. Table 42.2 lists the kinds and frequency of urologic complications following radical hysterectomy. Urinary incontinence of various types occurs in 20% to 50% of patients following radical hysterectomy for cervical cancer with between 5% and 12% of individuals severely handicapped by the disorder. Notably, one study found that 35% of patients were unhappy with their urinary dysfunction following radical hysterectomy, although all were satisfied with their posttreatment cancer outcomes. This likely reflects an acceptance of presumed necessary morbidities of aggressive cancer treatment. Recent advances in the technique of radical hysterectomy including tailoring the degree of dissection to the overall treatment goal as well as a nerve-sparing technique are emerging and may help to further ameliorate postoperative alterations in bladder function. The following will consider the specific bladder and urethral effects of radical hysterectomy.



Table 42.2

Long-term Effects of Radical Hysterectomy on Urethrovesical Function






























































































Study Patient Number Methods Follow-up Time Findings
623 IVP; cystoscopy; cystometry 20 year Fistula, atonic bladder pyelonephritis
27 IVP; cystoscopy; UDS 12 month Sensory loss, atonic bladder, incontinence, elevated PVR
22 IVP; cystoscopy; UDS 6-43 month Hypertonic bladder followed by sensory loss, stress incontinence
20 UDS 12 month Decreased urethral pressure, transient urinary retention (25%)
30 UDS 12 month Decreased urethral pressure, stress incontinence (3%)
15 UDS 7-12 month Motor and sensory loss (80%), decreased bladder capacity (30%)
58 Telephone interview 10 year SUI (12%), 36% mild incontinence from absent bladder sensation
27 UDS 17-32 month Severe SUI (7%)
12 IVP; UDS 12 month SUI (50%), atonic bladder (36%), motor and sensory loss (25% and 17%), impaired flow (17%), elevated PVR (25%)
22 Telephone interview 5-41 month SUI (70%), sensory loss (55%), impaired flow (75%), elevated PVR (10%)
61 Cystometry 7-236 month Atonic bladder (25%), low compliance (31%), detrusor instability (4%), elevated PVR (16%)
40 IVP; UDS 12 month Abdominal straining (85%), sensory loss (63%), high compliance (40%), low compliance (22%), SUI (55%)
9 IVP; UDS 14-36 year Impaired flow and elevated PVR (100%), sensory and motor loss (100%), low compliance (71%)
77 Questionnaire; UDS (24 pts) 12 month SUI (71%), impaired bladder compliance (25%)

UDS, Urodynamic study (flowmetry, cystometry, urethral profiles); IVP, intravenous pyelogram; PVR, postvoid residual volume; SUI, stress urinary incontinence.

Modified from Zullo MA, Manci N, Angioli R, Muzii L, Panici PB. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol . 2003;48:287.


Bladder Dysfunction


Despite documenting stable bladders on urodynamic studies of women following radical hysterectomy, the majority of studies report abnormal spontaneous contractions of the bladder. A number of studies have shown decreased bladder compliance and resultant increased bladder pressures in patients following radical hysterectomy. Table 42.3 lists these reported urodynamic bladder changes following radical hysterectomy. These findings, however, are usually transient with spontaneous resolution or development of bladder areflexia and overflow incontinence over the following year. Both and reported patients with permanent inability to void following radical hysterectomy, presumably from an atonic bladder. In a study of women who had undergone a radical hysterectomy no less than 10 years prior, found 18 of 20 had absent bladder contractility requiring abdominal straining to void. Detrusor function can be impaired irrespective of intravesical pressure. Decreased bladder compliance and increased intravesical pressure would be expected to correspond with increased flow rates and less residual urine, but this is not always the case following radical hysterectomy.



Table 42.3

Bladder Changes after Radical Hysterectomy








































































































Author Total Bladder Capacity Bladder Compliance Residual Volume
<9 Months >9 Months <9 Months >9 Months <9 Months >9 Months
NS NS c
NS NS c c NS
c c c
c c NS
c c NS
c c c c
c c c c c
c c c c c
NS NS NS 38% NS/40% ↑/23% ↓ c c
NS c NS c c c
c c c

NS, No change; c, not examined; CO2 cystoscopy, ↓ 14 days postoperative; ↓ decreased; ↑ increased.


The etiologies of bladder and urethral effects after radical hysterectomy are difficult to decipher. Several studies have investigated the effects of sparing some portion of the cardinal ligaments on bladder function. The concept has merit as studies confirm the presence of abundant nerve tissue in the cardinal and uterosacral ligaments, particularly at their site of origin along the pelvic sidewall. , and all documented less-impaired bladder function among patients undergoing radical hysterectomy in whom portions of the cardinal ligaments were preserved. The inferior hypogastric plexus consists mainly of parasympathetic fibers from sacral roots S3 and S4 as well as some sympathetic fibers from the lumbosacral trunk. These nerves are present at least in part in the cardinal and uterosacral ligaments and supply the large bowel (to the level of the internal anal sphincter), the bladder and urethra, and the entire genital tract. Division of these nerves during radical hysterectomy alters the neurologic control of the lower urinary tract, resulting in dysfunction. In 1973, Roman-Lopez and Barclay postulated that parasympathetic overdominance following radical hysterectomy accounted for the initial bladder dysfunction. However, this theory fell into disfavor when parasympatholytic agents did not reverse the bladder effects. Alternatively, argued that damage to the sympathetic portion of the hypogastric plexus accounted for the bladder dysfunction. Difficulty with this mechanism, however, arises in investigations such as that did not find any correlation between the radicality of the surgery and any lower urinary tract dysfunction. Moreover, discounted the effects of denervation, citing a German study wherein the amount of cardinal ligament resected did not correlate with degree of lower urinary tract dysfunction. They argued that direct operative trauma, edema, hematoma, and scar formation accounted for the majority of dysfunction following radical hysterectomy.


Detrusor sensation is diminished in every study of the effects of radical hysterectomy on lower urinary tract function. Cervical cancer per se probably does not affect bladder sensation. Following radical hysterectomy, patients report replacement of the normal bladder sensation with a vague sense of fullness in the lower abdomen. With lost physiologic cortical sensory input from the bladder following radical hysterectomy, patients may become aware of less sensitive indicators of vesical distention such as peritoneal stretching or pressure on adjacent abdominal viscera. Often this altered sensation improves over the course of a year. However, decreased bladder sensation can lead to bladder atony if careful early postoperative bladder drainage is not maintained.


Urethral Dysfunction


The etiology of urethral dysfunction after radical hysterectomy has not been clearly determined, although recent work suggests that outlet dysfunction works in concert with the known bladder dysfunction. The most consistent urodynamic finding following radical hysterectomy is decreased urethral pressure. The functional urethral length is decreased in many studies, although this appears to resolve over time. Table 42.4 catalogs the changes in the urethra following radical hysterectomy. Anatomic support defects resulting in stress incontinence are not usually found following radical hysterectomy. Notably, argued that anti-incontinence procedures designed to suspend the bladder neck would be largely unsuccessful because intrinsic sphincter deficiency is more often the etiology of urinary incontinence among these patients. The success of contemporary mid-urethral slings on treatment of urinary incontinent women following radical hysterectomy is beginning to emerge. reported on two patients with stress urinary incontinence following radical hysterectomy for cervical cancer treated with a single-incision mid-urethral sling. Both women reported favorable stress urinary incontinence (SUI) management outcomes, but one had a minor mesh extrusion and the other required treatment for urinary urgency. Given the general inferiority of single-incision mid-urethral slings to the traditional retropubic approach, the success in this case portends mid-urethral sling surgical approaches are a viable option for SUI management among women who have had cervical cancer.


May 16, 2019 | Posted by in GYNECOLOGY | Comments Off on The Effects of Gynecologic Cancer on Lower Urinary Tract Function

Full access? Get Clinical Tree

Get Clinical Tree app for offline access